China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of complement Factor B Inhibitor Combined with Prednisone and Cyclophosphamide in Treating Relapsed or Refractory C3d-Positive Warm Autoimmune Hemolytic Anemia: A Multicenter, Prospective Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135106
Registration Time: 2026/10/26
Type: Interventional study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344812
Published by HT Digital Content Services with permission from Health ...